| Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease A Swimm, CR Giver, Z DeFilipp, S Rangaraju, A Sharma, ... Blood, The Journal of the American Society of Hematology 132 (23), 2506-2519, 2018 | 150 | 2018 |
| Acute lymphoblastic leukemia, version 2.2021, NCCN clinical practice guidelines in oncology PA Brown, B Shah, A Advani, P Aoun, MW Boyer, PW Burke, ... Journal of the National Comprehensive Cancer Network 19 (9), 1079-1109, 2021 | 138 | 2021 |
| Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation AK Nooka, HR Johnson, JL Kaufman, CR Flowers, A Langston, C Steuer, ... Biology of Blood and Marrow Transplantation 20 (6), 852-857, 2014 | 39 | 2014 |
| Similar survival for patients undergoing reduced-intensity total body irradiation (TBI) versus myeloablative TBI as conditioning for allogeneic transplant in acute leukemia JL Mikell, EK Waller, JM Switchenko, S Rangaraju, Z Ali, M Graiser, ... International Journal of Radiation Oncology* Biology* Physics 89 (2), 360-369, 2014 | 13 | 2014 |
| Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemia S Arora, C Zainaldin, S Bathini, U Gupta, S Worth, K Bachiashvili, ... Leukemia Research 117, 106844, 2022 | 8 | 2022 |
| Methods of managing graft versus host disease EK Waller, CR Giver, S Rangaraju US Patent 9,458,217, 2016 | 7 | 2016 |
| Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents C Zainaldin, S Arora, S Bathini, U Gupta, V Pandya, S Bae, S Worth, ... Leukemia & Lymphoma 63 (13), 3245-3248, 2022 | 3 | 2022 |
| IDH1 inhibitor-induced neutrophilic dermatosis in a patient with acute myeloid leukemia S Dunn-Valadez, S Bathini, C Elston, S Rangaraju, A Di Stasi, S Worth, ... Cancer Treatment and Research Communications 31, 100560, 2022 | 3 | 2022 |
| Incidence of unprovoked venous thromboembolic events in patients with chronic lymphocytic leukemia LA Katkish, S Rangaraju, TS Rector, AA Gravely, GJ Johnson, MA Klein, ... Leukemia & Lymphoma 59 (2), 509-511, 2018 | 3 | 2018 |
| Hypomethylating agent/venetoclax versus intensive chemotherapy in adults with relapsed or refractory acute myeloid leukaemia. O Jamy, K Lin, S Worth, K Bachiashvili, S Rangaraju, P Vachhani, ... British Journal of Haematology 198 (3), 2022 | 2 | 2022 |
| Administration of a Tryptophan Metabolite, Indole-3-Carboxaldehyde, Reduces Graft Versus Host Disease Morbidity and Mortality and Enhances Gastrointestinal Barrier Function in … EK Waller, CR Giver, S Rangaraju, A Swimm, A Sharma, M Qayed, ... Blood 124 (21), 2420, 2014 | 2 | 2014 |
| Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia O Jamy, K Diebold, K Davis, K Bachiashvili, S Rangaraju, P Vachhani, ... Bone Marrow Transplantation 58 (7), 823-825, 2023 | 1 | 2023 |
| Outcomes of 3-versus 5-day administration schedule of consolidation cytarabine in adults with acute myeloid leukemia (AML). K Diebold, K Bachiashvili, OH Jamy, P Vachhani, KN Godby, R Bhatia, ... Journal of Clinical Oncology 41 (16_suppl), 7014-7014, 2023 | 1 | 2023 |
| Safe and effective use of imatinib to treat Philadelphia chromosome positive acute lymphoblastic leukemia during pregnancy S Ashraf, J Wolfson, P Vachhani, S Rangaraju, K Bachiashvili, R Bhatia, ... Journal of adolescent and young adult oncology 11 (6), 617-620, 2022 | 1 | 2022 |
| A phase 1 study of NTX-301, an oral DNMT1 inhibitor, in patients with MDS and AML (trial in progress). P Vachhani, GSG Murthy, O Jamy, K Bachiashvili, S Rangaraju, T Cole, ... Journal of Clinical Oncology 40 (16_suppl), TPS7077-TPS7077, 2022 | 1 | 2022 |
| Student loan debt and visa status influence on career choices for hematology and medical oncology fellows in the United States. K Al-Issa, S Rangaraju, AA Al-Hader Journal of Clinical Oncology 38 (15_suppl), 11024-11024, 2020 | 1 | 2020 |
| Incidence of Unprovoked Venous Thromboembolic Events in Patients with Chronic Lymphocytic Leukemia (CLL) LA Katkish, S Rangaraju, TS Rector, GJ Johnson, MA Klein, P Gupta Blood 126 (23), 1110, 2015 | 1 | 2015 |
| Addition of single dose gemtuzumab ozogamicin to intensive induction chemotherapy in core-binding factor acute myeloid leukemia G Bourne, K Diebold, M Espinoza-Gutarra, Z Al-Kadhimi, K Bachiashvili, ... Leukemia Research 139, 107467, 2024 | | 2024 |
| Addition of Single Dose Gemtuzumab Ozogamicin to Intensive Induction Chemotherapy in Core-Binding Factor Acute Myeloid Leukemia G Bourne, K Diebold, M Espinoza-Gutarra, Z Al-Kadhimi, K Bachiashvili, ... Blood 142, 5848, 2023 | | 2023 |
| Idarubicin and Cytarabine with and without Midostaurin for FLT3-Mutated Acute Myeloid Leukemia K Diebold, S Worth, K Bachiashvili, P Vachhani, S Rangaraju, ... Blood 142, 5910, 2023 | | 2023 |
